PXL/HO/Cir-074/2023-24                                                                            Date: 06.11.2023

Hyderabad

Dear Sir/Madam,

Subject: Draft National Pharmaceutical Policy 2023 issued by Department of Pharmaceuticals for stakeholder consultation

Greetings from Pharmexcil!

We are pleased to inform you that the Department of Pharmaceuticals has released an approach paper on the draft National Pharmaceutical Policy, 2023 for stakeholder consultation with a vision of "Empowering Health for All: Pioneering Excellence in Pharmaceuticals”.

Draft National Pharmaceutical Policy, 2023 emphasizing on a holistic policy approach to address the challenges faced by Indian pharmaceutical industries and provide definitive policy interventions to enhance the collective ecosystem.The policy aspires to establish India as a global leader in pharmaceuticals backed by world class infrastructure and enabling ecosystem, where cutting-edge research and development lead to the creation of innovative and affordable healthcare solutions, fostering a healthier, more prosperous nation and contributing to global health equity, aligning with the vision of Amrit Kaal Vision@2047.

The objectives of the National Pharma Policy encompasses five key pillars

1. Fostering Global Pharmaceutical Leadership,
2. Promoting Self Reliance,
3. Advancing Health Equity and Accessibility,
4. Attracting Foreign Direct Investments and
5. Enhancing Regulatory Efficiency in Indian Pharmaceutical Sector

A High-level Task Force will be set up in the Department of Pharmaceuticals under the Minister for Chemicals and Fertilizers to guide and review the implementation of the Policy. The Task Force will draw upon resource persons from Departments and Organizations related to the implementation as the success of the policy requires coordinated action by several agencies.

The Department of Pharmaceuticals has invited comments from the stakeholders on Draft policy and the comments are to be sent to vaibhavraina.dop@govcontractor.in. Kindly note that the last date for submission of comments is 30^th November 2023.

With Regards

Udaya Bhaskar

Director General